(Q33857924)

29 July 2017

title

Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans (English)

1 reference

29 July 2017

M Fujita

1

1 reference

29 July 2017

S W Woods

2

1 reference

29 July 2017

N P Verhoeff

3

1 reference

29 July 2017

A Abi-Dargham

4

1 reference

29 July 2017

R M Baldwin

5

1 reference

29 July 2017

S S Zoghbi

6

1 reference

29 July 2017

J C Soares

7

1 reference

29 July 2017

P A Jatlow

8

1 reference

29 July 2017

J H Krystal

9

1 reference

29 July 2017

N Rajeevan

10

1 reference

29 July 2017

D S Charney

11

1 reference

29 July 2017

J P Seibyl

12

1 reference

29 July 2017

R B Innis

13

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

European Journal of Pharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

368

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

161-172

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Development of stable cell lines expressing different subtypes of GABAA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Nonlinear regression in parametric activation studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Comparison of Alprazolam, Imipramine, and Placebo in the Treatment of Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Spatial registration and normalization of images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Clinical pharmacokinetics of alprazolam. Therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Diazepam disposition determinants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Low-dose alprazolam augments motor activity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Chronic use of benzodiazepines and psychomotor and cognitive test performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Bi-directional changes in the levels of messenger RNAs encoding gamma-aminobutyric acidA receptor alpha subunits after flurazepam treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Decrease in [3H]flunitrazepam receptor binding in rats tolerant to the effects of nitrazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Dosimetry of iodine-123 iomazenil in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Formation of 1-[123I]iodobutane in labeling [123I]iomazenil by iododestannylation: implications for the reaction mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

Use-dependent regulation of GABAA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900013-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00013-8

1 reference

29 July 2017

1 reference